Home > News > LANL Completes Successful Analysis of Antibodies
November 15th, 2006
LANL Completes Successful Analysis of Antibodies
Abstract:
Lumera Corporation (Nasdaq:LMRA), an emerging leader in the field of nanotechnology, announced today that its proprietary Heterodimer Protein Technology (HPT) and ProteomicProcessor™ were both successfully used to analyze single chain antibodies from Los Alamos National Laboratory (LANL).
Source:
Businesswire
Related News Press |
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Tools
Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023
The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||